RetinalGenix Technologies Inc. financial data

Symbol
RTGN on OTC
Location
Petaluma, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 14 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 0.15% %
Debt-to-equity -101% % 2.8%
Return On Equity 147% % -39%
Return On Assets -25292% % -259%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 18,604,961 shares 2.8%
Common Stock, Shares, Outstanding 18,604,961 shares 3%
Entity Public Float $15,506,590 USD 0%
Common Stock, Value, Issued $1,860 USD 3%
Weighted Average Number of Shares Outstanding, Basic 18,579,776 shares 3.4%
Weighted Average Number of Shares Outstanding, Diluted 18,579,776 shares 3.4%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $152,369 USD -80%
General and Administrative Expense $1,387,194 USD 2.7%
Net Income (Loss) Attributable to Parent $2,672,495 USD 33%
Earnings Per Share, Basic 0 USD/shares 43%
Earnings Per Share, Diluted 0 USD/shares 43%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current $92 USD -100%
Property, Plant and Equipment, Net $31 USD -76%
Operating Lease, Right-of-Use Asset $4,914 USD -36%
Assets $7,001 USD -92%
Liabilities, Current $2,173,729 USD 12%
Operating Lease, Liability, Noncurrent $6,002 USD -15%
Liabilities $2,179,731 USD 12%
Retained Earnings (Accumulated Deficit) $17,235,490 USD -18%
Stockholders' Equity Attributable to Parent $2,172,730 USD -17%
Liabilities and Equity $7,001 USD -92%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $187,222 USD -14%
Net Cash Provided by (Used in) Financing Activities $184,873 USD -14%
Common Stock, Shares Authorized 80,000,000 shares 0%
Common Stock, Shares, Issued 18,604,961 shares 3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $2,349 USD -105%
Deferred Tax Assets, Valuation Allowance $4,610,716 USD 39%
Deferred Tax Assets, Gross $4,610,716 USD 39%
Operating Lease, Liability $6,002 USD -22%
Depreciation $25 USD 0%
Lessee, Operating Lease, Liability, to be Paid $15,659 USD -35%
Operating Lease, Liability, Current $988 USD 49%
Lessee, Operating Lease, Liability, to be Paid, Year Two $5,517 USD -32%
Lessee, Operating Lease, Liability, to be Paid, Year One $8,114 USD 3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $9,657 USD -41%
Lessee, Operating Lease, Liability, to be Paid, Year Three $5,517 USD
Deferred Tax Assets, Operating Loss Carryforwards $1,766,033 USD 23%
Preferred Stock, Shares Authorized 40,000,000 shares 0%
Operating Lease, Payments $7,689 USD
Additional Paid in Capital $15,060,900 USD 19%
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Interest Expense $3,840 USD -17%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%